Oldfield Karen, Eathorne Allie, Maijers Ingrid, Beasley Richard, Semprini Alex, Braithwaite Irene
Senior Clinical Research Fellow, Medical Research Institute of New Zealand; PhD Student, Victoria University, Wellington.
Research Fellow, Medical Research Institute of New Zealand, Wellington.
N Z Med J. 2020 Sep 25;133(1522):96-111.
To determine what patients presenting to general practice (GP) understand about the use of cannabis as a medicine, beliefs of how this may impact their medical conditions and interactions with doctors.
An in-person survey of 134 GP patients from four GP practices throughout the North Island of New Zealand undertaken from November 2018 to October 2019.
Fifty-five percent of the sample were female, with 40% of all participants aged 60 years plus. Ninety-one percent of participants indicated they would use a prescribed medicinal cannabis product while 45% reported they believed it may be of some benefit to their medical condition. Of those who believed it beneficial, 71% indicated they thought it useful for pain relief. Participants indicated comfort discussing medicinal cannabis use with GPs and specialists (92% respectively); however, less than 10% had done this.
Just under half of patients surveyed believe that medicinal cannabis products may be helpful to their condition, and while the majority report willingness, few have discussed this with their GP or specialist. There is need for accessible, accurate information regarding the use of cannabis-based medicine for patients and doctors alike to guide the patient-doctor consultation and decrease barriers to open discussion.
确定到全科医疗诊所（GP）就诊的患者对大麻作为药物的使用了解多少，他们认为这可能如何影响其病情，以及与医生的互动情况。
2018年11月至2019年10月期间，对新西兰北岛四个全科医疗诊所的134名GP患者进行了面对面调查。
样本中有55%为女性，所有参与者中有40%年龄在60岁及以上。91%的参与者表示他们会使用处方医用大麻产品，45%的参与者报告称他们认为这可能对其病情有一定益处。在那些认为有益的人中，71%表示他们认为其对缓解疼痛有用。参与者表示在与GP和专科医生讨论医用大麻使用时感到自在（分别为92%）；然而，不到10%的人这样做过。
接受调查的患者中略少于一半的人认为医用大麻产品可能对其病情有帮助，虽然大多数人表示愿意，但很少有人与他们的GP或专科医生讨论过此事。需要为患者和医生提供关于使用大麻类药物的可获取、准确的信息，以指导医患咨询并减少公开讨论的障碍。
